Therapeutic Targets Database
BIDD Pharmainformatics Databases


TTD Drug ID: DNCL003062

Drug Information
CompanyLundbeck;Takeda Pharmaceuticals U.S.A.
IndicationAnxiety disorders (pediatric)
[ICD9: 300   ICD10: F40-F42]
Phase II    
Depressive disorders (pediatric)
[ICD9: 296   ICD10: F30-F39]
Phase II    
Generalized anxiety disorder
[ICD9: 300.02   ICD10: F41.1]
Phase III    
Generalized anxiety disorder (see also depression)
[ICD9: 300, 300.02, 311   ICD10: F32, F40-F42, F41.1]
Phase III    
Major depressive disorder
[ICD9: 296.2, 296.3   ICD10: F32, F33]
Major depressive disorder (see also anxiety)
[ICD9: 296.2, 296.3, 300   ICD10: F32, F33, F40-F42]
Phase III    

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
Canonical SMILESCC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C    
CAS NumberCAS 508233-74-7
PubChem Compound IDCID 9966051.
SuperDrug ATC IDN06AX26


Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.

Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links


Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543